Harrow (HROW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it has entered into a ...

HROW sets ambitious price targets in a new 3-year plan while showcasing strong drug growth and leveraging a proven model for ...

Fintel reports that on July 11, 2025, Cantor Fitzgerald initiated coverage of Harrow (NasdaqGM:HROW) with a Overweight ...

South Korea’s Samsung Bioepis today announced it has entered into a license, development and commercialization agreement (DCA ...

LOS ANGELES, July 15, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that ...

Harrow (NASDAQ:HROW) stock gains as Cantor Fitzgerald gives an Overweight rating for the company, citing a conservative outlook. Read more here.

Pomerantz LLP is investigating claims on behalf of investors of Harrow, Inc. (“Harrow” or the “Company”) (NASDAQ: HROW). Such investors are advised ...

He finished with a 20-26 record overall and lost both of his bowl game appearances. He went on to make several stops over the next two decades, never staying with one program for more than four ...

Here's the list of options activity happening in today's session: These bullet-by-bullet explanations have been constructed using the accompanying table.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...